ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

86 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50,164,476 shares of 98,567,360 outstanding shares and own 50.89% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (11,077,927 shares), ORBIMED ADVISORS LLC (8,740,887 shares), FMR LLC (5,369,362 shares), RA CAPITAL MANAGEMENT, L.P. (3,009,678 shares), SR ONE CAPITAL MANAGEMENT, LP (3,009,677 shares), Rubric Capital Management LP (2,990,564 shares), K2 PRINCIPAL FUND, L.P. (2,872,148 shares), BAKER BROS. ADVISORS LP (2,006,451 shares), Nextech Invest Ltd. (1,910,029 shares), and VANGUARD GROUP INC (1,687,920 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.